Chemical Compound

Rifamycin SV

CAS Registry Number 6998-60-3
Rifamycin SV chemical structure
Primary Record

Rifamycin SV

In stock
4,402 g
Purity
99.0 %
CAS
6998-60-3

Compound Identifiers & Properties

CAS
6998-60-3
PubChem CID
6324616
SMILES
C[C@H]1/C=C/C=C(\C(=O)NC2=CC(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C
Canonical SMILES
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(cc(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C

Names & Synonyms

  • Rifamycin SV
  • RIFAMYCIN
  • Rifocin
  • Rifamicine SV
  • Rifomycin SV
  • Rifamicina
  • Rifamycine
  • Rifamycinum
  • Rifocyn
  • Rifamycins
  • Rifomycins
  • Aemcolo
  • Rifacin
  • Rifocina
  • Rifocyna
  • Rifogal
  • Tuborin
  • Otafa
  • rifamycin-sv
  • Rifamycine Chibret
  • RIFOMYCIN
  • Rifamicina Colirio
  • Rifamycin SV MMX
  • Sodium rifomycin SV
  • Monosodium rifamycin SV
  • Rifamycine [INN-French]
  • Rifamycinum [INN-Latin]
  • DU69T8ZZPA
  • Rifamycin sodium salt
  • Rifamicina [INN-Spanish]
  • 6998-60-3
  • Rifaximin EP Impurity C
  • Rifamycin SV sodium salt
  • RIFAMYCIN SODIUM
  • UNII-DU69T8ZZPA
  • 3-Methansulfinyl-phenol
  • RefChem:57064
  • RIFAMYCIN [INN]
  • Rifamycin (USAN/INN)
  • RIFAMYCIN [USAN]
  • GlyTouCan:G97409XF
  • Rifamycin [INN:BAN:DCF]
  • rifamycin SV, sodium salt
  • Rifamycin, monosodium salt
  • DTXSID1032014
  • D0FX2Q
  • RIFAMYCIN SV [MI]
  • RIFAMYCIN [WHO-DD]
  • HJYYPODYNSCCOU-ODRIEIDWSA-N
  • C37H47NO12
  • Rifamycin [BAN:DCF:INN]
  • CHEBI:29673
  • CB-01-11
  • rifamycin SV, monosodium salt
  • SCHEMBL151824
  • 6998-60-3 (free acid)
  • EINECS 230-273-3
  • C37H47NO12.Na
  • Rifamycin [USAN:INN:BAN:DCF]
  • CHEMBL437765
  • GTPL4570
  • DTXCID9012014
  • SCHEMBL29355202
  • SCHEMBL29649054
  • CHEBI:26580
  • HY-B1907A
  • A07AA13
  • D06AX15
  • J04AB03
  • S02AA12
  • 29),26-octaen-13-yl acetate
  • NSC133100
  • GLXC-20256
  • M-14
  • C37-H47-N-O12.Na
  • RIFAMYCIN SV [EP IMPURITY]
  • G97409XF
  • 8248AH
  • BBF-02634
  • BDBM50391000
  • LMPK05000005
  • MFCD01741300
  • AKOS024281286
  • C37-H47-N-O12
  • ZINC169633673
  • CID6324616
  • CS-O-02237
  • DB11753
  • LS-2172
  • NSC 133100
  • CID:6324616
  • 15105-92-7
  • SC-49540
  • SID:53786745
  • SID:53790785
  • ST044225
  • R-75-1
  • RIFAXIMIN IMPURITY C [EP IMPURITY]
  • 2841A
  • CS-0092130
  • FT-0701680
  • First International Standard for Rifamycin SV
  • C12044
  • D02549
  • A899902
  • C023808
  • D012294
  • SR-01000872597
  • SR-01000872597-1
  • (pentahydroxy-methoxy-heptamethyl-dioxo-[?]yl) acetate
  • Q26270990
  • Rifamycin SV, an antibiotic produced by certain strains of Streptomyces mediterranei, or the same substance produced by any other means
  • [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
  • 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2-H)-dione, 21-acetate
  • Rifamycin (oral controlled-release, gastrointestinal-specific)
  • (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate
  • (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-Pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25(29),26-octaen-13-yl acetate
  • 2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate
  • 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione 21-acetate
  • 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan, rifamycin deriv.
  • Rifamycin (oral controlled-release, gastrointestinal-specific), Cosmo/Dr Falk/Santarus
  • ((7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo(23.3.1.14,7.05,28)triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl) acetate
  • (7S,11S,12R,13S,14R,15R,16R,17S,18S,19Z,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo(23.3.1.1^(4,7).0^(5,28))triaconta-1,3,5(28),9,19,21,25(29),26-octaen-13-yl acetate
  • (7S,11S,12R,13S,14R,15R,16R,17S,18S,19Z,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1^{4,7}.0^{5,28}]triaconta-1,3,5(28),9,19,21,25(29),26-octaen-13-yl acetate
  • (7S,11S,13S,17S,18S,12R,14R,15R,16R)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7 ,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1<4, 7>.0<5,28>]triaconta-1(28),2,4,9,19,21,25(
  • (7S,11S,13S,17S,18S,12R,14R,15R,16R)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7 ,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1<4, 7>.0<5,28>]triaconta-1(28),2,4,9,19,21,25(29),26-octaen-13-yl acetate
  • 2,7-(Epoxy[1,11,13]pentadecatrienoimino)naphtho[2,1-b]furan-1,11(2H)-dione, 21-(acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, (2S,16S,17S,18R,19R,20R,21S,22R,23S)-
  • 2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione,5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate
  • 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate
  • 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate, monosodium salt
  • 230-273-3